title: Tacrolimus and new onset diabetes mellitus: the effect of steroid weaning.
authors.affiliation: Zena and Michael A. Weiner Cardiovascular Institute, Mt. Sinai Medical Center, New York, NY 10029, USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Baran
authors.forename: J
authors.initials: J
authors.lastname: Ashkar
authors.forename: I D
authors.initials: ID
authors.lastname: Galin
authors.forename: D
authors.initials: D
authors.lastname: Sandler
authors.forename: L
authors.initials: L
authors.lastname: Segura
authors.forename: M C
authors.initials: MC
authors.lastname: Courtney
authors.forename: R
authors.initials: R
authors.lastname: Correa
authors.forename: M
authors.initials: M
authors.lastname: Chan
authors.forename: S L
authors.initials: SL
authors.lastname: Lansman
authors.forename: D
authors.initials: D
authors.lastname: Spielvogel
authors.forename: J
authors.initials: J
authors.lastname: Cheng
authors.forename: A L
authors.initials: AL
authors.lastname: Gass
mesh_terms: D000328:Adult; D003920:Diabetes Mellitus / Q000139:chemically induced* / Q000517:prevention & control; D004334:Drug Administration Schedule; D016027:Heart Transplantation / Q000009:adverse effects / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D015994:Incidence; D011237:Predictive Value of Tests; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus